This
blazon of biologic works by blocking accurate proteins on blight beef that
animate the blight to grow. Afatinib blocks proteins alleged epidermal advance
agency receptors (EGFR). Cancers that accept these receptors are alleged EGFR
positive.
Between
10 and 15 humans out of every 100 with non baby corpuscle lung blight (10 to
15%) accept EGFR absolute cancer. Doctors analysis your blight beef to see if
they accept the receptors afore you accept this treatment.
Afatinib
may compress the blight or stop it growing for a time.
No comments:
Post a Comment